Last updated: 2026-09-23 05:55:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
NewGenIvf Group Limited (NIVF) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.84, with a market capitalization of $1.54M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.70 to $1,539.00. This page covers its latest market performance, valuation, price trends and company information.
$1.54M | |
$0.75 | |
$1,771,200.00 | |
$0.70 | |
$0.72 | |
257.23K | |
176.11K | |
-- | |
$1,539.00 | |
$0.70 | |
-- | |
-- |
NewGenIvf Group Limited (NIVF) last closed at $0.72 as of 2026-09-22 23:28:00, unchanged from the previous close of $0.72.
During the latest regular trading session, NIVF traded between $0.70 and $1,771,200.00, with a volume of 257.23K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, NewGenIvf Group Limited (NIVF) moved from $1.06 to $0.84, representing a decline of 20.85% ($0.22).
The stock traded between $0.70 and $1.15 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 104.93 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 0.0%
NIVF is currently trading at $0.84, placing it 0.0% of the way from its 52-week low of $0.70 to its 52-week high of $1,539.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
NewGenIvf Group Ltd is a tech-forward, diversified, multi-jurisdictional entity capitalizing on emerging opportunities across real estate development, digital asset innovation, and reproductive health solutions. The company offers two services, namely: in vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and fertility referral services, like surrogacy and ancillary caring services. It derives maximum revenue from in vitro fertilization (IVF) treatment service. Its Geographical presence is in China / HK SAR, Thailand, Cambodia, U.S and Kyrgyzstan. The company derives maximum revenue from Kyrgyzstan.
| Employees | 87 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of NewGenIvf Group Limited (NIVF) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.